![]() |
市場調查報告書
商品編碼
2024480
周邊血管醫療設備市場報告:按器材類型、最終用戶和地區分類(2026-2034 年)Peripheral Vascular Devices Market Report by Device Type, End User, and Region 2026-2034 |
||||||
2025年,全球周邊血管醫療設備市場規模達130億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到212億美元,2026年至2034年的複合年成長率(CAGR)為5.42%。這一市場成長主要得益於微創手術技術的持續創新以及心血管疾病盛行率的不斷上升。此外,隨著醫療專業人員越來越重視改善患者預後,對動脈粥狀硬化斑塊切除術器械、支架和血管成形術用氣球的需求也在不斷成長,推動了整個醫療產業的市場顯著擴張。
周邊血管疾病(PVD)是一種循環系統疾病,由心臟和大腦以外的血管狹窄、阻塞或痙攣引起。這些疾病會減少血流,導致虛弱、疼痛、壞疽、腿部除毛、麻木和肌肉沉重等症狀。周邊血管醫療設備,例如血管成形術導管、末梢用導管導引線、下腔靜脈濾器、血管支架和抗栓塞裝置(EPD),用於治療動脈阻塞和狹窄。這些阻塞,尤其是在周邊血管系統中,是由斑塊積聚引起的,斑塊積聚會使血管變窄,減少流向全身的血液。周邊血管醫療設備安全可靠,可最大限度地降低感染和刺激的風險,改善血流,並透過動脈輸送富氧血液。
對微創手術的需求日益成長
在全球周邊血管醫療設備市場,微創手術的需求日益成長,主要促進因素包括更高的成本效益、更短的恢復時間和更低的併發症發生率。諸如動脈粥狀硬化斑塊切除術系統、支架和血管成形術用氣球等器械因其能減輕病患負擔,進而有效治療周邊動脈疾病,正迅速普及。此外,隨著越來越多的患者和醫療機構選擇這些手術,旨在提高這些器械精準性和有效性的技術創新也在快速發展。同時,這一趨勢正在推動市場擴張,尤其是在醫療系統日益重視個人化治療和良好治療效果的背景下。根據產業報告預測,微創手術器械市場規模預計將從2023年的140.6億美元成長到2032年的284.83億美元。
血管醫療設備的技術創新
對周圍血管醫療設備市場的分析表明,持續的技術進步正顯著推動全球市場的擴張。影像技術、藥物釋放型球囊和生物可吸收支架的改進正在增強周圍血管疾病的治療效果。 2023年5月發表在學術期刊《心血管介入》(Cardiovascular Interventions)上的一篇研究論文顯示,藥物釋放型球囊(DCB)在治療支架內再血管再阻塞(一種與周圍血管疾病相關的併發症)方面,實現了58%的五年無再次干預率。此外,這些進步使得治療更加精準,改善了患者預後,並減少了再次治療的需求。同時,數據分析和遠端監測等數位健康解決方案的日益普及,也使得慢性血管疾病的管理更加有效。此外,隨著製造商加大研發投入,將尖端解決方案推向市場,改良型周邊血管醫療設備的整體需求也穩定成長。
周邊動脈疾病(PAD)盛行率增加
根據周邊血管醫療設備市場調查,周邊動脈疾病(PAD)盛行率的不斷上升是全球市場的主要促進因素。隨著人口老化以及吸菸、糖尿病和高血壓等危險因子發病率的增加,全球PAD病例數正在逐步增加。國際糖尿病聯盟(IDF)預測,到2030年,糖尿病患者人數將達到6.43億,到2045年將達到7.83億。此外,患者數量的激增也推動了對高效血管器械的需求,以用於治療和控制疾病。同時,患者和醫療專業人員對PAD的認知顯著提高,促使早期診斷和早期療育廣泛應用。因此,用於緩解動脈阻塞和改善血流的血管成形術用氣球、支架和其他各種醫療設備的市場正在擴大,顯著促進了周邊血管醫療設備市場的成長。
The global peripheral vascular devices market size reached USD 13.0 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 21.2 Billion by 2034, exhibiting a growth rate (CAGR) of 5.42% during 2026-2034. The market growth is significantly propelled by ongoing innovations in minimally invasive procedures and amplifying prevalence of cardiovascular disorders. Moreover, demand for atherectomy devices, stents, and angioplasty balloons is heightening as healthcare providers emphasize on enhancing patient outcomes, driving substantial market expansion across medical industry.
Peripheral vascular disease (PVD) is a circulatory condition caused due to the narrowing, blockage, or spasms in the blood vessels located outside the heart and brain. Such occurrences reduce the blood flow through the vessels, resulting in weakness, pain, gangrene, hair loss on the legs, numbness, and muscle heaviness. Peripheral vascular devices, such as angioplasty catheters, peripheral guidewires, vena cava filters, stent grafts, and embolic protection devices (EPD), are used to treat artery blockages and narrowing. These blockages, particularly found in the peripheral vasculature, are caused by plaque build-up, which limits the blood vessels and reduces blood flow to the body parts. Peripheral vascular devices are safe, minimize the risk of infection and irritation, improve blood flow, and supply oxygenated blood through arteries.
Heightening Demand for Minimally Invasive Procedures
The global peripheral vascular devices market is witnessing an escalating demand for minimally invasive procedures, primarily driven by the requirement for cost-effectiveness, minimized recovery times, and reduced complication rates. Devices like atherectomy systems, stents, and angioplasty balloons are rapidly gaining momentum due to their capability to treat peripheral artery diseases with reduced trauma to the patient. Moreover, as healthcare patients and providers are increasingly opting for such procedures, innovations in technology are rapidly growing to improve the accuracy and efficacy of such devices. In addition, this trend is boosting the market expansion, particularly as healthcare systems are currently focusing on patient-specific treatments and successful outcomes. As per industry reports, the minimally invasive surgery devices market is anticipated to expand from USD 14.06 billion in 2023 to USD 28.483 billion by the year 2032.
Technological Innovations in Vascular Devices
The peripheral vascular devices market analysis indicates that constant technological advancements are significantly steering the global market expansion. Innovations, such as enhanced imaging techniques, drug-coated balloons, and bioresorbable stents, are improving the efficacy of treatments for peripheral vascular diseases. According to a research article published in the journal Cardiovascular Interventions, in May 2023, drug-coated balloons (DCBs) attained a 5-year freedom from reintervention procedures of 58% for in-stent restenosis, a condition associated with peripheral vascular diseases. Moreover, such advancements facilitate more accurate interventions, enhance patient outcomes, and lower the requirement for repeat procedures. In addition, the increasing incorporation of digital health solutions, such as data analytics and remote monitoring, is enabling better management of chronic vascular disorders. Furthermore, as manufacturers are heavily investing in research and development projects to bring leading-edge solutions to the market, the overall need for upgraded peripheral vascular devices is stably escalating.
Rising Prevalence of Peripheral Artery Disease (PAD)
The peripheral vascular devices market research indicates that the amplifying prevalence of peripheral artery disease (PAD) is a crucial driver of the global market. With an elevation in aging population and the heightening incidents of risk factors, such as smoking, diabetes, and hypertension, PAD cases are gradually becoming more prevalent globally. According to the International Diabetes Federation, the number of individuals suffering with diabetes will elevate to 643 million by 2030 and 783 million by the year 2045. Moreover, this accelerating patient pool is bolstering the demand for efficient vascular devices to treat as well as manage the condition. In addition, as awareness of PAD is notably fueling worldwide among both patients and healthcare providers, early diagnosis and intervention are also surging. Resultantly, there is a proliferating market for angioplasty balloons, stents, and various other devices developed to mitigate arterial blockages and enhance circulation, substantially contributing to the peripheral vascular devices market growth.
Peripheral vascular stents accounts for the majority of the market share
Hospitals and clinics hold the largest share of the industry
North America leads the market, accounting for the largest peripheral vascular devices market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for peripheral vascular devices.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.